Lichen International (LICN) Common Equity (2021 - 2025)

Lichen International (LICN) has reported Common Equity for 5 consecutive years, with $70.6 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Common Equity fell 6.64% year-over-year to $70.6 million in Q4 2025; TTM through Dec 2025 was $70.6 million, a 6.64% decrease from a year earlier, with the FY2025 full-year figure at $70.6 million, down 6.64% from the prior year.
• Common Equity was $70.6 million for Q4 2025 at Lichen International, up from $64.3 million in the prior quarter.
• Over five years, Common Equity peaked at $75.6 million in Q4 2024 and troughed at $36.8 million in Q4 2021.
• A 5-year average of $59.1 million and a median of $62.8 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity jumped 49.41% in 2023 and declined 7.93% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $36.8 million in 2021, then increased by 11.61% to $41.1 million in 2022, then surged by 49.41% to $61.4 million in 2023, then increased by 23.03% to $75.6 million in 2024, then fell by 6.64% to $70.6 million in 2025.
• The last three Common Equity figures came in at $70.6 million (Q4 2025), $64.3 million (Q2 2025), and $75.6 million (Q4 2024), per Business Quant data.